106 related articles for article (PubMed ID: 2905665)
21. Localization of dynorphin-induced neurotoxicity in rat spinal cord.
Stewart P; Isaac L
Life Sci; 1989; 44(20):1505-14. PubMed ID: 2566882
[TBL] [Abstract][Full Text] [Related]
22. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.
Hauser KF; Foldes JK; Turbek CS
Exp Neurol; 1999 Dec; 160(2):361-75. PubMed ID: 10619553
[TBL] [Abstract][Full Text] [Related]
23. A strychnine-sensitive site is involved in dynorphin-induced paralysis and loss of the tail-flick reflex.
Stewart P; Isaac L
Brain Res; 1991 Mar; 543(2):322-6. PubMed ID: 1676332
[TBL] [Abstract][Full Text] [Related]
24. Dynorphin induces partially reversible paraplegia in the rat.
Faden AI; Jacobs TP
Eur J Pharmacol; 1983 Jul; 91(2-3):321-4. PubMed ID: 6137396
[TBL] [Abstract][Full Text] [Related]
25. Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats.
Przewłocki R; Shearman GT; Herz A
Neuropeptides; 1983 Jan; 3(3):233-40. PubMed ID: 16229165
[TBL] [Abstract][Full Text] [Related]
26. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats.
Stevens CW; Weinger MB; Yaksh TL
Eur J Pharmacol; 1987 Jun; 138(2):299-302. PubMed ID: 2887441
[TBL] [Abstract][Full Text] [Related]
27. Effects of dynorphin A (1-17) on motor function and spinal intracellular messenger systems in rat.
Zhang Z; Li F; Ren M; Liu J
Chin Med Sci J; 1996 Jun; 11(2):63-8. PubMed ID: 9387410
[TBL] [Abstract][Full Text] [Related]
28. Increased dynorphin immunoreactivity in spinal cord after traumatic injury.
Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
Regul Pept; 1985 May; 11(1):35-41. PubMed ID: 2861626
[TBL] [Abstract][Full Text] [Related]
29. Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation.
Tan-No K; Takahashi H; Nakagawasai O; Niijima F; Sakurada S; Bakalkin G; Terenius L; Tadano T
Int Rev Neurobiol; 2009; 85():191-205. PubMed ID: 19607971
[TBL] [Abstract][Full Text] [Related]
30. Dynorphin A (1-13): in vivo opioid antagonist actions and non-opioid anticonvulsant effects in the rat flurothyl test.
Tortella FC; Holaday JW
NIDA Res Monogr; 1986; 75():539-42. PubMed ID: 2893282
[TBL] [Abstract][Full Text] [Related]
31. Effect of prodynorphin-derived opioid peptides on the ovulatory luteinizing hormone surge in the proestrous rat.
Zhang Q; Gallo RV
Endocrine; 2002 Jun; 18(1):27-32. PubMed ID: 12166621
[TBL] [Abstract][Full Text] [Related]
32. Spinal subarachnoid injection of somatostatin causes neurological deficits and neuronal injury in rats.
Long JB
Eur J Pharmacol; 1988 May; 149(3):287-96. PubMed ID: 2900768
[TBL] [Abstract][Full Text] [Related]
33. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
34. The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord.
Przewlocki R; Lasoń W; Höllt V; Silberring J; Herz A
Brain Res; 1987 Jun; 413(2):213-9. PubMed ID: 2886190
[TBL] [Abstract][Full Text] [Related]
35. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury.
Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
Ann Neurol; 1985 Apr; 17(4):386-90. PubMed ID: 2860844
[TBL] [Abstract][Full Text] [Related]
36. Intrathecal substance P analogue causes motor dysfunction in the rat.
Matsumura H; Sakurada T; Hara A; Kuwahara H; Ando R; Sakurada S; Kisara K
Neuropharmacology; 1985 Aug; 24(8):811-3. PubMed ID: 2427968
[TBL] [Abstract][Full Text] [Related]
37. N-methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies.
Bakshi R; Ni RX; Faden AI
Brain Res; 1992 May; 580(1-2):255-64. PubMed ID: 1380394
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical evidence for different opioid systems in the rat superior cervical ganglion as revealed by imipramine treatment and receptor blockade.
Folan JC; Heym C
J Chem Neuroanat; 1989; 2(2):107-18. PubMed ID: 2574980
[TBL] [Abstract][Full Text] [Related]
39. Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.
Shen KF; Crain SM
Brain Res; 1995 Feb; 673(1):30-8. PubMed ID: 7757476
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a differential postnatal development of proenkephalin B (= prodynorphin)-derived opioid peptides in the rat hypothalamus.
Seizinger BR; Grimm C; Herz A
Endocrinology; 1984 Sep; 115(3):926-35. PubMed ID: 6547667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
